Sensitivity analysis of the primary endpoint from the N-MOmentum study of inebilizumab in NMOSD

Bruce A.C. Cree, Jeffrey L. Bennett, Ho Jin Kim, Brian G. Weinshenker, Sean J. Pittock, Dean Wingerchuk, Kazuo Fujihara, Friedemann Paul, Gary R. Cutter, Romain Marignier, Ari J. Green, Orhan Aktas, Hans Peter Hartung, Ian M. Williams, Jorn Drappa, Dewei She, Daniel Cimbora, William Rees, John N. Ratchford, Eliezer Katz